| Research contract revenue | 1.6M |
| Research and development, including costs of research contracts | |
| General and administrative | 3.54M |
| Total operating expenses | 12.51M |
| Loss from operations | -10.91M |
| Other income, net | 39K |
| Change in fair value of warrants | |
| Net income (loss) | -10.85M |
| Net income (loss) per share - basic | |
| Net income (loss) per share - diluted | |
| Weighted average common shares outstanding to compute net income (loss) per share - basic | |
| Weighted average common shares outstanding to compute net income (loss) per share - diluted | |